HST Global (HST Global) Loans Receivable : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is HST Global Loans Receivable?

HST Global's Loans Receivable for the quarter that ended in Dec. 2023 was $0.00 Mil.

HST Global Loans Receivable Historical Data

The historical data trend for HST Global's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HST Global Loans Receivable Chart

HST Global Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Loans Receivable

Get a 7-Day Free Trial

HST Global Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Loans Receivable	Get a 7-Day Free Trial															-	-	-	-	-

HST Global Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

HST Global Loans Receivable Related Terms

Thank you for viewing the detailed overview of HST Global's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

HST Global (HST Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HST Global Inc (OTCPK:HSTC) » Definitions » Loans Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 Research Drive, Hampton, VA, USA, 23666

Website

http://www.hstglobal.com

HST Global Inc is an integrated health and wellness biotechnology company. It is engaged in developing and acquiring a network of Wellness Centers that are focused on the homeopathic and alternative treatment of late-stage cancer. Further, it primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing. The activities are generally carried out through the region of the United States.

Executives

Wesley D. Tate	officer: CFO and Secretary	C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Ronald R. Howell	director, officer: CEO and Chairman	C/O HEALTH SOURCE TECHNOLOGIES, INC., 150 RESEARCH DRIVE, HAMPTON VA 23666
Pnc Labs Inc	10 percent owner	429 W PLUMB LANE, RENO NV 89509
Chun Ka Tsun	director, 10 percent owner, officer: CEO	TG WANASPORTS MANAGEMENT HOLDINGS, 8/F NO 211 JOHNSTON ROAD, WAN CHAI K3 00000
Chen Tsz King	10 percent owner	FUGU ENTERPRISE INC, UNIT A 8TH FLOOR NO 65 SING WOOD ROAD, HAPPY VALLEY K3 00000
Li Sze Tang	10 percent owner	FLAT G, 8/FL TOWER THREE, THE WATERFRONT, 1 AUSTIN ROAD WEST, TST K3 00000
Andre E Todd	director	746 HILLGIRT CIRCLE, OAKLAND CA 94610
Aaron Etra	director	1350 AVE OF AMERICAS, 29TH FLOOR, NEW YORK NY 10019
Communications Holding Corp	10 percent owner
Alan Lew	director, 10 percent owner, officer: President	2 DOGWOOD DR, SCARSDALE NY 10583

HST Global (HST Global) Headlines

From GuruFocus

HST Global, Inc. Announces Entering into an Agreement to Purchase a Financial Services Revenue Sharing Contract.

By Marketwired Marketwired • 08-23-2019